NSN 6505-01-411-2723
Part Details | LORAZEPAM INJECTION
6505-01-411-2723
Alternate Parts: 950129, 95-0129, NDC00641604925, NDC00641-6049-25, NDC00641604525, NDC00641-6045-25, NDC00641600325, NDC00641-6003-25, 6505-01-411-2723, 01-411-2723, 6505014112723, 014112723
| Supply Group (FSG) | NSN Assigned | NIIN | Item Name Code (INC) |
|---|---|---|---|
| 65 | MAR 21, 1995 | 01-411-2723 | 50832 ( LORAZEPAM INJECTION ) |
REFERENCE DRAWINGS & PICTURES
Cross Reference | NSN 6505-01-411-2723
| Part Number | Cage Code | Manufacturer |
|---|---|---|
| 95-0129 | 89875 | DEFENSE LOGISTICS AGENCYDIRECTORATE OF MEDICAL MATERIEL |
| NDC00641-6049-25 | 32655 | WEST-WARD PHARMACEUTICALS CORP. |
| NDC00641-6045-25 | 32655 | WEST-WARD PHARMACEUTICALS CORP. |
| NDC00641-6003-25 | 32655 | WEST-WARD PHARMACEUTICALS CORP. |
Technical Data | NSN 6505-01-411-2723
| Characteristic | Specifications |
|---|---|
| PRIMARY CONTAINER CONTENT QUANTITY | 1.000 MILLILITERS |
| PRIMARY CONTAINER TYPE | VIAL |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | BY4.000 MILLIGRAMS LORAZEPAM |
| TOTAL PRIMARY CONTAINER QUANTITY | 25 |
| SPECIAL FEATURES | REFRIGERATION REQUIRED BETWEEN 2-8 DEGREES C. DEA CONTROLLED SUBSTANCE CLASS IV. |
| PROTECTIVE STORAGE FEATURE | REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | LORAZEPAM INJECTION 4MG/ML 1ML VIAL 25S PG |
| CONTROLLED SUBSTANCE CLASSIFICATION | SCHEDULE IV |
